BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reed X, Schumacher-Schuh A, Hu J, Bandres-Ciga S. Advancing Personalized Medicine in Common Forms of Parkinson's Disease through Genetics: Current Therapeutics and the Future of Individualized Management. J Pers Med 2021;11:169. [PMID: 33804504 DOI: 10.3390/jpm11030169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Dehestani M, Liu H, Gasser T. Polygenic Risk Scores Contribute to Personalized Medicine of Parkinson's Disease. J Pers Med 2021;11:1030. [PMID: 34683174 DOI: 10.3390/jpm11101030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Grétarsdóttir HM, Widman E, Johansson A, Nyholm D. Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice. J Pers Med 2021;11:720. [PMID: 34442364 DOI: 10.3390/jpm11080720] [Cited by in F6Publishing: 3] [Reference Citation Analysis]